This Viewpoint advocates for more careful consideration of families and children in policymaking surrounding naloxone coprescribing or accessibility. Share: Previous Post Effects on Body Mass Index After the Philadelphia Beverage Tax Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Errors in Text, Figure, and Supplement Clinical Practice Guidelines Temporal Trends in Neurodevelopmental Outcomes to 2 Years After Extremely Preterm Birth Clinical Practice Guidelines JAMA Pediatrics Clinical Practice Guidelines Is Low-Fat Dairy an Appropriate Recommendation for Children? Clinical Practice Guidelines Modeling Cost and Outcomes of SARS-CoV-2 School Testing Programs—Reply Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.